XML 54 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Acquisitions and Assets Held for Sale - Narrative (Details) - USD ($)
1 Months Ended 3 Months Ended
Dec. 17, 2021
Feb. 02, 2021
Jan. 19, 2021
Jan. 31, 2022
Jan. 19, 2021
Apr. 30, 2022
Jan. 31, 2022
Jan. 31, 2021
Oct. 31, 2021
Feb. 01, 2021
Business Acquisition [Line Items]                    
Finite-lived intangible asset, useful life             14 years      
Goodwill       $ 3,835,700,000     $ 3,835,700,000   $ 2,574,000,000  
Contingent consideration paid             0      
Privately-Held Medical Device Company, Developed Mara Water Vapor Ablation System                    
Business Acquisition [Line Items]                    
Goodwill                   $ 0
Disposal Group, Held-for-sale, Not Discontinued Operations | Equity Interest In Wholly-Owned Subsidiary                    
Business Acquisition [Line Items]                    
Percentage of voting interests sold   50.00%                
Ownership interest retained after sale of business   50.00%                
Asset impairment             $ 0      
Customer relationships                    
Business Acquisition [Line Items]                    
Finite-lived intangible asset, useful life             13 years      
Trademarks                    
Business Acquisition [Line Items]                    
Finite-lived intangible asset, useful life             14 years      
Term Loan Facility 2021 | Line of Credit                    
Business Acquisition [Line Items]                    
Proceeds from line of credit $ 1,500,000,000                  
Generate Life Sciences                    
Business Acquisition [Line Items]                    
Equity interests acquired 100.00%                  
Payments to acquire business $ 1,666,000,000                  
Revenue of acquiree since acquisition date       33,800,000            
Net income of acquiree since acquisition date       $ 1,600,000            
Goodwill $ 1,292,600,000                  
Generate Life Sciences | Customer relationships                    
Business Acquisition [Line Items]                    
Finite-lived intangible asset, useful life             13 years      
Generate Life Sciences | Trademarks                    
Business Acquisition [Line Items]                    
Finite-lived intangible asset, useful life             14 years      
Cook Medical's Reproductive Health Business | Subsequent Event | Forecast                    
Business Acquisition [Line Items]                    
Payments to acquire business           $ 675,000,000        
Aggregate consideration           875,000,000        
Payables incurred in acquisition           200,000,000        
Cook Medical's Reproductive Health Business | Subsequent Event | Forecast | Payables, First Installment                    
Business Acquisition [Line Items]                    
Payables incurred in acquisition           50,000,000        
Cook Medical's Reproductive Health Business | Subsequent Event | Forecast | Payables, Second Installment                    
Business Acquisition [Line Items]                    
Payables incurred in acquisition           50,000,000        
Cook Medical's Reproductive Health Business | Subsequent Event | Forecast | Payables, Third Installment                    
Business Acquisition [Line Items]                    
Payables incurred in acquisition           50,000,000        
Cook Medical's Reproductive Health Business | Subsequent Event | Forecast | Payables, Fourth Installment                    
Business Acquisition [Line Items]                    
Payables incurred in acquisition           $ 50,000,000        
Privately-Held Medical Device Company                    
Business Acquisition [Line Items]                    
Payments to acquire business     $ 40,900,000              
Equity investment gain realized before acquisition of remaining equity interest         $ 11,500,000          
Contingent consideration     37,900,000   37,900,000          
Increase in contingent liability             $ 3,500,000 $ 56,800,000    
Privately-Held Medical Device Company, Portion Attributable To Former Equity Interest Owners                    
Business Acquisition [Line Items]                    
Undiscounted range of the contingent consideration, minimum     0   0          
Undiscounted range of the contingent consideration, maximum     139,100,000   139,100,000          
Contingent consideration     $ 30,200,000   $ 30,200,000